Suraksha Diagnostic informs about press release

Suraksha Diagnostic Ltd. | Hospital & Healthcare Services | Healthcare | BSE: 544293 | NSE: SURAKSHA

07 Mar 2025 Evaluate

In continuation to intimation letter dated 08 February 2025 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suraksha Diagnostic has enclosed the press release in relation to the appointment of the Ravindra K S as the Chief Financial Officer with effect from 01 March 2025, who will also act as a Group Chief Financial Officer of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Manipal Health Enter	716.15
Apollo Hospital Ent.	8850.00
Fortis Healthcare	887.30
Max Healthcare Inst.	1037.20
Narayana Hrudayalay.	1867.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.